Proprietary Development

Microfluidics - Photonics - Drug Delivery - Diagnostics

Blueacre Technology is developing proprietary technology that will allow microneedles to be interfaced with microfluidic, photonic and integrated circuitry.

This technology is applicable to

	Transdermal Drug Delivery
	Molecular Diagnostics
	Chemical Analysis
	Environmental Monitoring

Blueacre Technology is developing these processes at the wafer level ensuring scalability and compatibility with existing fabrication lines.